Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026

Standard BioTools (NASDAQ: LAB) will report its first quarter 2026 financial results on May 5, 2026, to be released after the U.S. market close.

Rhea-AI Summary

Standard BioTools (NASDAQ: LAB) will report its first quarter 2026 financial results on May 5, 2026, to be released after the U.S. market close.

Investors can expect a post-close release and likely an accompanying conference call or investor materials referenced by the company.

Argus Apr 21 session

-1.00% close to close Open Argus

Details

News Market Reaction – LAB

On Apr 21, the day this news came out, LAB closed 1.00% below the previous close.

Data tracked by StockTitan Argus for the Apr 21 session.

Previous Earnings date Reports

1 past event · Latest: Feb 10

Same Type 1 event

1. Feb 10

   Earnings date announcement

   24h Move

   -1.6%

   Set timing for Q4 and full-year 2025 results release after market close.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish its first quarter 2026 financial results on Tuesday, May 5, 2026, after U.S. market close.

About Standard BioTools Inc.

Standard BioTools Inc. (NASDAQ: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook^®, LinkedIn, and YouTube™.

Limited Use Label License and other terms may apply: standardbio.com/legal/terms-and-conditions/.
Patent and License Information: standardbio.com/legal/notices.
©2026 Standard BioTools Inc. All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Standard BioTools (LAB) release Q1 2026 results?

Standard BioTools will publish its Q1 2026 results on May 5, 2026 after U.S. market close. According to the company, the timing allows investors to review the release and any supplemental materials before the next trading day.

How can investors access Standard BioTools (LAB) Q1 2026 financial results on May 5, 2026?

Investors can access the results via the company's investor relations page and SEC filings after the close. According to the company, the release will be posted online and may include financial tables and a press statement.

Will Standard BioTools (LAB) hold a conference call for the May 5, 2026 earnings release?

The company has not specified a call in this announcement; the primary notice covers the release timing. According to the company, any webcast or call details typically follow the earnings release or investor relations notice.

What time should traders expect Standard BioTools (LAB) Q1 2026 results on May 5, 2026?

Results are expected after the U.S. market close on May 5, 2026, typically after 4:00 PM ET. According to the company, the exact posting will occur following market close and will be available online.

Will Standard BioTools (LAB) provide accompanying financial tables with the May 5, 2026 release?

The announcement indicates a standard quarterly release schedule but does not list attachments. According to the company, detailed financial tables and metrics are commonly included with quarterly results releases.

How should investors prepare for Standard BioTools (LAB) Q1 2026 results on May 5, 2026?

Investors should plan to review the post-close release and any follow-up webcast or filing the next morning. According to the company, monitoring the investor relations site will provide official materials and timing updates.